Home » US FDA Guidance Details Emergency Production Plans
US FDA Guidance Details Emergency Production Plans
January 14, 2010
Drugmakers that are the sole or primary source for certain key drugs need to be able to continue production during a pandemic and should create emergency
production plans that can delay or modify some good manufacturing practices (GMPs), the U.S. Food and Drug Administration (FDA) says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor